Cigna is trading 4.3% down at $282.00 after reporting strong second-quarter results and raising its 2026 outlook, as investors take profits despite the beat.

  • Revenue and EPS both exceeded analyst expectations, leading to an increase in full-year guidance.
  • Management raised the company's 2026 earnings outlook during the earnings release and conference call.
  • The negative price reaction is attributed to profit-taking and a valuation reassessment amid broader sector and macro pressures.